The market hasn't valued BlueScope at its true value for over a decade.
This is a pretty resilient performance for bottom of the cycle conditions. EBIT at around $700 million )forecast for the year) isn't a bad effort considering the OLD BlueScope that nearly went bankrupt would have run at losses.
US Steel spreads have slowly increased from their lows which is promising.
- Forums
- ASX - By Stock
- Ann: 1H FY2025 Results ASX Release
BSL
bluescope steel limited
Add to My Watchlist
0.00%
!
$23.08

The market hasn't valued BlueScope at its true value for over a...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$23.08 |
Change
0.000(0.00%) |
Mkt cap ! $10.12B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 563 | $24.54 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.47 | 1224 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 29 | 23.170 |
1 | 7 | 23.140 |
5 | 149 | 23.120 |
2 | 372 | 23.100 |
2 | 373 | 23.070 |
Price($) | Vol. | No. |
---|---|---|
23.270 | 168 | 3 |
23.280 | 94 | 2 |
23.330 | 59 | 2 |
23.340 | 39 | 2 |
23.370 | 44 | 1 |
Last trade - 09.53am 30/06/2025 (20 minute delay) ? |
Featured News
BSL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online